# Chicago Atlantic Real Estate Finance, Inc.: financial statements, quarterly

REFI · Nasdaq · CIK 1867949 · [Real estate](/sectors/real-estate.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/refi.md) · [Financials](/companies/refi/financials.md) · [Filings](/companies/refi/filings.md) · [Insiders](/companies/refi/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/refi/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Interest expense | $m | [1.4](/filings/0000950170-24-122763.md) | [1.7 d](/filings/0000950170-24-029644.md) | [2.1](/filings/0000950170-24-053919.md) | [1.8](/filings/0000950170-24-092263.md) | [1.8](/filings/0000950170-24-122763.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $m | [0.0](/filings/0000950170-24-122763.md) | [0.0 d](/filings/0000950170-25-037616.md) | [0.0](/filings/0000950170-25-064974.md) | [0.0](/filings/0000950170-25-104543.md) | [0.0](/filings/0001193125-25-263522.md) | [0.0 d](/filings/0001193125-26-103027.md) | [0.0](/filings/0001193125-26-210274.md) | [0.0](/filings/0001193125-26-343398.md) | [0.0](/filings/0001193125-25-263522.md) | [0.0 d](/filings/0001193125-26-103027.md) | [0.0](/filings/0001193125-26-210274.md) | [0.0](/filings/0001193125-26-343398.md) |
| Net income | $m | [10.0](/filings/0000950170-24-122763.md) | [9.4 d](/filings/0000950170-25-037616.md) | [8.7](/filings/0000950170-25-064974.md) | [9.2](/filings/0000950170-25-104543.md) | [11.2](/filings/0001193125-25-263522.md) | [7.9 d](/filings/0001193125-26-103027.md) | [10.0](/filings/0001193125-26-210274.md) | [8.9](/filings/0001193125-26-343398.md) | [8.9](/filings/0001193125-25-263522.md) | [8.2 d](/filings/0001193125-26-103027.md) | [4.8](/filings/0001193125-26-210274.md) | [7.5](/filings/0001193125-26-343398.md) |
| Diluted EPS | $ per share | [0.54](/filings/0000950170-24-122763.md) | not reported | [0.47](/filings/0000950170-25-064974.md) | [0.46](/filings/0000950170-25-104543.md) | [0.56](/filings/0001193125-25-263522.md) | not reported | [0.47](/filings/0001193125-26-210274.md) | [0.41](/filings/0001193125-26-343398.md) | [0.42](/filings/0001193125-25-263522.md) | not reported | [0.23](/filings/0001193125-26-210274.md) | [0.34](/filings/0001193125-26-343398.md) |
| Basic EPS | $ per share | [0.55](/filings/0000950170-24-122763.md) | not reported | [0.48](/filings/0000950170-25-064974.md) | [0.47](/filings/0000950170-25-104543.md) | [0.57](/filings/0001193125-25-263522.md) | not reported | [0.48](/filings/0001193125-26-210274.md) | [0.42](/filings/0001193125-26-343398.md) | [0.42](/filings/0001193125-25-263522.md) | not reported | [0.23](/filings/0001193125-26-210274.md) | [0.35](/filings/0001193125-26-343398.md) |

- Revenue: not reported
- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [8.7](/filings/0001213900-23-084499.md) | [7.9](/filings/0000950170-25-037616.md) | [6.9](/filings/0000950170-24-053919.md) | [7.1](/filings/0000950170-24-092263.md) | [6.8](/filings/0000950170-24-122763.md) | [26.4](/filings/0001193125-26-103027.md) | [9.9](/filings/0000950170-25-064974.md) | [35.6](/filings/0000950170-25-104543.md) | [28.9](/filings/0001193125-25-263522.md) | [14.9](/filings/0001193125-26-343398.md) | [27.9](/filings/0001193125-26-210274.md) | [13.4](/filings/0001193125-26-343398.md) |
| Total assets | $m | [352](/filings/0001213900-23-084499.md) | [359](/filings/0000950170-25-037616.md) | [384](/filings/0000950170-24-053919.md) | [386](/filings/0000950170-24-092263.md) | [366](/filings/0000950170-24-122763.md) | [435](/filings/0001193125-26-103027.md) | [415](/filings/0000950170-25-064974.md) | [455](/filings/0000950170-25-104543.md) | [427](/filings/0001193125-25-263522.md) | [425](/filings/0001193125-26-343398.md) | [436](/filings/0001193125-26-210274.md) | [462](/filings/0001193125-26-343398.md) |
| Total liabilities | $m | [76.5](/filings/0001213900-23-084499.md) | [87.4](/filings/0000950170-25-037616.md) | [97.7](/filings/0000950170-24-053919.md) | [93.8](/filings/0000950170-24-092263.md) | [70.4](/filings/0000950170-24-122763.md) | [126](/filings/0001193125-26-103027.md) | [104](/filings/0000950170-25-064974.md) | [145](/filings/0000950170-25-104543.md) | [117](/filings/0001193125-25-263522.md) | [117](/filings/0001193125-26-343398.md) | [133](/filings/0001193125-26-210274.md) | [160](/filings/0001193125-26-343398.md) |
| Long-term debt | $m | not reported | not reported | not reported | [76.8](/filings/0000950170-24-092263.md) | [54.0](/filings/0000950170-24-122763.md) | [49.1](/filings/0000950170-25-037616.md) | [49.2](/filings/0000950170-25-064974.md) | [49.2](/filings/0000950170-25-104543.md) | [49.3](/filings/0001193125-25-263522.md) | [49.3](/filings/0001193125-26-103027.md) | [49.4](/filings/0001193125-26-210274.md) | [49.5](/filings/0001193125-26-343398.md) |
| Current portion of debt | $m | [274](/filings/0001213900-23-084499.md) | [285](/filings/0000950170-24-122763.md) | [288](/filings/0000950170-24-053919.md) | [291](/filings/0000950170-24-092263.md) | [220](/filings/0000950170-24-122763.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $m | [276](/filings/0000950170-24-122763.md) | [272](/filings/0001193125-26-103027.md) | [286](/filings/0000950170-25-104543.md) | [293](/filings/0001193125-25-263522.md) | [295](/filings/0001193125-25-263522.md) | [309](/filings/0001193125-26-343398.md) | [311](/filings/0001193125-26-343398.md) | [310](/filings/0001193125-26-343398.md) | [310](/filings/0001193125-25-263522.md) | [308](/filings/0001193125-26-343398.md) | [303](/filings/0001193125-26-343398.md) | [302](/filings/0001193125-26-343398.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebt
- Current portion of debt: us-gaap:DebtCurrent
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [1.0 d](/filings/0000950170-24-122763.md) | [15.5 d](/filings/0000950170-25-037616.md) | [6.9](/filings/0000950170-25-064974.md) | [6.2 d](/filings/0000950170-25-104543.md) | [8.2 d](/filings/0001193125-25-263522.md) | [1.8 d](/filings/0001193125-26-103027.md) | [7.6](/filings/0001193125-26-210274.md) | [6.5 d](/filings/0001193125-26-343398.md) | [8.2 d](/filings/0001193125-25-263522.md) | [6.5 d](/filings/0001193125-26-103027.md) | [3.2](/filings/0001193125-26-210274.md) | [9.1 d](/filings/0001193125-26-343398.md) |
| Dividends paid | $m | [8.6 d](/filings/0000950170-24-122763.md) | [8.6 d](/filings/0000950170-25-037616.md) | [13.9](/filings/0000950170-25-064974.md) | [9.2 d](/filings/0000950170-25-104543.md) | [9.3 d](/filings/0001193125-25-263522.md) | [9.3 d](/filings/0001193125-26-103027.md) | [13.6](/filings/0001193125-26-210274.md) | [10.4 d](/filings/0001193125-26-343398.md) | [9.9 d](/filings/0001193125-25-263522.md) | [9.9 d](/filings/0001193125-26-103027.md) | [9.9](/filings/0001193125-26-210274.md) | [10.9 d](/filings/0001193125-26-343398.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Dividends paid: us-gaap:PaymentsOfDividends

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [17.8](/filings/0001213900-23-084499.md) | [18.0](/filings/0000950170-24-053919.md) | [18.3](/filings/0000950170-24-092263.md) | [18.6](/filings/0000950170-24-122763.md) | [18.6](/filings/0000950170-25-064974.md) | [19.9](/filings/0000950170-25-104543.md) | [20.1](/filings/0001193125-25-263522.md) | [21.3](/filings/0001193125-26-210274.md) | [21.5](/filings/0001193125-26-343398.md) | [21.5](/filings/0001193125-25-263522.md) | [21.5](/filings/0001193125-26-210274.md) | [21.7](/filings/0001193125-26-343398.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 25,621,146 at 2026-08-06, from the cover of the [10-Q filed 2026-08-11](/filings/0001193125-26-343398.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:49 ET. No prices; not investment advice.